Pictet Asset Management (UK)’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Pictet Asset Management (UK)’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.31M	Buy	192,684 +99,365	+106%	+$803K	﹤0.01%	1066
2021 Q1	$659K	Buy	+93,319	New	+$672K	﹤0.01%	1135
2018 Q1	–	Sell	-788,246	Closed	-$14.1M	–	910
2017 Q4	$14.1M	Buy	788,246 +126,251	+19%	+$2.63M	0.04%	435
2017 Q3	$16.6M	Buy	661,995 +315,010	+91%	+$7.33M	0.05%	396
2017 Q2	$6.96M	Buy	+346,985	New	+$7.67M	0.02%	547

Other funds holding PRTK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management (UK)'s PRTK Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Paratek Pharmaceuticals, Inc. (PRTK) stake by 106% in Q2 2021, buying an estimated $803K and bringing the position to 192,684 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1066.

Pictet Asset Management (UK) first reported a position in PRTK in Q2 2017 and has held it in 5 quarters since. The position peaked at $16.6M in Q3 2017. 116 funds tracked by Wall St. Rank hold PRTK as of Q2 2021.

Pictet Asset Management (UK) held 192,684 shares of Paratek Pharmaceuticals, Inc. worth $1.31M as of Q2 2021.
Pictet Asset Management (UK) bought 99,365 Paratek Pharmaceuticals, Inc. shares in Q2 2021, an estimated $803K.
Paratek Pharmaceuticals, Inc. made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1066 holding.
Pictet Asset Management (UK) first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2017 and has held it in 5 quarters since.
Pictet Asset Management (UK)'s Paratek Pharmaceuticals, Inc. position peaked at $16.6M in Q3 2017.
116 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.